William Blair & Company
MDLN

William Blair & Company’s Medline Inc MDLN Stock Holding History

William Blair & Company’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$51.9M Buy
1,165,430
+1,117,380
+2,325% +$49.3M 0.15% 139
2025
Q4 		$2.02M Buy
+48,050
New +$2.03M 0.01% 743

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

William Blair & Company's MDLN Position: Q1 2026 in Review

William Blair & Company increased its Medline Inc (MDLN) stake by 2,325% in Q1 2026, buying an estimated $49.3M and bringing the position to 1,165,430 shares worth $51.9M. The position accounts for 0.15% of the portfolio, ranked #139.

William Blair & Company first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • William Blair & Company held 1,165,430 shares of Medline Inc worth $51.9M as of Q1 2026.
  • William Blair & Company bought 1,117,380 Medline Inc shares in Q1 2026, an estimated $49.3M.
  • Medline Inc made up 0.15% of William Blair & Company's portfolio in Q1 2026, its #139 holding.
  • William Blair & Company first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.